Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optima CC pilot study in cardiogenic shock
2009-017081-23Phase 4Completed
- Sponsor
- CHRU Nancy
- Start
- Feb 2010
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of epinephrine and norepinephrine in cardiogenic shock (2 arms), sponsored by CHRU Nancy. Primary endpoints: Treatment efficacy by blinded expert panel consensus, Cardiac index and 10 more. Started Feb 2010; status: completed.
02
Drugs
epinephrinenorepinephrine
03
Conditions
cardiogenic shock
Beyond the preview
Go deeper on 2009-017081-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017081-23.